Clinical Trial

Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Evaluating the efficacy and safety of adebrelizumab for the adjuvant treatment of esophageal squamous cell cancer.
Trial Details
NCT Number NCT07266480
Lead Sponsor Hebei Medical University Fourth Hospital
Conditions Squamous Oesophageal Cancer
Enrollment 142 participants
Start Date 2025-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2030-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-05